Navigation Links
Pradaxa Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Pradaxa Litigation, Bernstein Liebhard LLP Reports
Date:5/5/2013

New York, New York (PRWEB) May 05, 2013

Pradaxa lawsuits continue to move forward in a federal litigation currently underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to the court’s website, the next Status Conference in the Pradaxa litigation has been scheduled for May 14th at 9:00 a.m. Court documents indicate that just over 550 claims have been filed in the litigation by alleged victims of Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We regularly receive inquiries from patients who have allegedly suffered serious instances of Pradaxa bleeding. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered life-threatening episodes of internal bleeding that may be associated with use of this blood thinner.

Pradaxa Bleeding
Pradaxa was approved by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in patients with atrial fibrillation. According to a recent Reuters report, Pradaxa sales rose more than 11% last year, and passed the $1 billion threshold that denotes blockbuster status in the pharmaceutical industry.* Pradaxa was touted as an improvement over decades-old warfarin, but Bloomberg.com recently reported that regulators in several countries have issued alerts regarding the drug’s potential to cause dangerous internal bleeding in some patients. **

Among other things, there exists no readily-available antidote for the internal bleeding that can sometimes occur in patients treated with Pradaxa. In 2011 alone, the FDA received reports of 542 deaths and 3,781 side-effect incidents tied to Pradaxa, Bloomberg.com said. Earlier this year, the Institute for Safe Medicine Practices renewed concerns about Pradaxa bleeding, when it revealed that an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.***

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information is available at Bernstein Liebhard LLP’s website, or by calling 1-877-779-1414 to speak with a Pradaxa lawyer today.

*reuters.com/article/2013/04/24/boehringer-results-idUSL6N0DB1WB20130424 (April 24, 2013)
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html (December 12, 2012)
***ismp.org/quarterwatch/pdfs/2012Q2.pdf (January 9, 2013)

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-side-effects/prweb10702509.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
2. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
3. DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
4. 2013 Cases Involving Pradaxa Internal Bleeding Problem Allegations Now Being Investigated by Resource4thePeople Lawyers
5. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
6. DrugRisk Update: New Pradaxa Study Questions FDA Safety Conclusion
7. Pradaxa Internal Bleeding Claims Are Now Being Reviewed by Resource4thePeople Attorneys
8. d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
9. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
10. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
11. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow solution provider ... 20 – 22 in San Francisco. As part of the Tri-Conference expo, which ... workflow solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... Vincent J. Angotti has been appointed ... company,s board of directors, effective Monday, March 6, ... experience leading executive and commercial teams at public ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Function, Application, Cancer Type, Technology - Forecast to 2025" report ... ... grow at a CAGR of around 28.6% over the next decade ... Some of the prominent trends that the market is witnessing include ...
Breaking Medicine Technology: